These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7905338)

  • 1. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
    Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
    Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
    Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
    Chan SL; Pallett AL; Morgan NG
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
    Chan SL; Brown CA; Morgan NG
    Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.
    Brown CA; Loweth AC; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Feb; 108(2):312-7. PubMed ID: 8095415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
    Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080.
    Ball AJ; Flatt PR; McClenaghan NH
    Pharmacol Res; 2000 Dec; 42(6):575-9. PubMed ID: 11058411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
    Chan SL; Atlas D; James RF; Morgan NG
    Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
    Chan SL; Morgan NG
    Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat.
    Berdeu D; Gross R; Puech R; Loubatières-Mariani MM; Bertrand G
    Eur J Pharmacol; 1995 Feb; 275(1):91-8. PubMed ID: 7774667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
    Chan SL; Dunne MJ; Stillings MR; Morgan NG
    Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
    Chan SL; Mourtada M; Morgan NG
    Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
    Mourtada M; Smith SA; Morgan NG
    Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
    Fagerholm V; Scheinin M; Haaparanta M
    Br J Pharmacol; 2008 Jul; 154(6):1287-96. PubMed ID: 18493247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
    Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
    Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans.
    Tsoli E; Chan SL; Morgan NG
    Eur J Pharmacol; 1995 Sep; 284(1-2):199-203. PubMed ID: 8549627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
    Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
    Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.
    Chan SL; Brown CA; Scarpello KE; Morgan NG
    Br J Pharmacol; 1994 Aug; 112(4):1065-70. PubMed ID: 7952865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
    Abdel-Zaher AO; Ahmed IT; El-Koussi AD
    Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.